ÂÜÀòÂÒÂ×

Pierre Pujol is the Chief Business Officer at Trilo Therapeutics, overseeing the development of fully synthetic macrocyclic peptidomimetics for ADC drug development. Pierre co-founded Airlib Inc, an IOT solution for interactive traffic pollution maps, and served as the CEO of Oakbio Inc., focusing on industrial emissions capture. With a background in strategic planning and business development at global pharmaceutical companies, Pierre brings a wealth of experience in portfolio analysis and M&A activities. Their educational background includes an MBA from INSEAD, an MSc & Engineering degree from AgroParisTech, and a BSc in Biology from Université Paul Sabatier Toulouse III.